Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions
Author(s) -
Erin E. Swinstead,
Tina Branscombe Miranda,
Ville Paakinaho,
Songjoon Baek,
Ido Goldstein,
Mary E. Hawkins,
Tatiana Karpova,
David A. Ball,
Davide Mazza,
Luke D. Lavis,
Jonathan B. Grimm,
Tatsuya Morisaki,
Lars Grøntved,
Diego M. Presman,
Gordon L. Hager
Publication year - 2016
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2016.02.067
Subject(s) - foxa1 , biology , transcription factor , chromatin , estrogen receptor , pioneer factor , nuclear receptor , genetics , microbiology and biotechnology , gene , enhancer , breast cancer , cancer
The estrogen receptor (ER), glucocorticoid receptor (GR), and forkhead box protein 1 (FoxA1) are significant factors in breast cancer progression. FoxA1 has been implicated in establishing ER-binding patterns though its unique ability to serve as a pioneer factor. However, the molecular interplay between ER, GR, and FoxA1 requires further investigation. Here we show that ER and GR both have the ability to alter the genomic distribution of the FoxA1 pioneer factor. Single-molecule tracking experiments in live cells reveal a highly dynamic interaction of FoxA1 with chromatin in vivo. Furthermore, the FoxA1 factor is not associated with detectable footprints at its binding sites throughout the genome. These findings support a model wherein interactions between transcription factors and pioneer factors are highly dynamic. Moreover, at a subset of genomic sites, the role of pioneer can be reversed, with the steroid receptors serving to enhance binding of FoxA1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom